Patients with PROCRIT , the transfusion requires were treats an average of 2.5 units of red blood cells, while patients treated with Aranesp , which received a transfusion an average of 3.9 units of red blood cells, requires a statistically significant difference. Furthermore, from week five of the study until its conclusion, received 13 % of patients with PROCRIT treated transfusions, compared with 18 % of patients treated with Aranesp . Produceder, is not reached statistical significance. Both agents had similar safety profiles.. Patients were treated with PROCRIT also transfused with a lower number of red blood cells throughout the study.
These last results are from a prospective, randomized, open-label, multicenter trial that PROCRIT PROCRIT and Aranesp in the treatment of chemotherapy-related anemia. Enrollment in the study was stopped when a planned interim analysis, statistical analysis of the first 305 patients have completed four weeks of therapy showed that the mean increase in hemoglobin was significantly higher in patients treated with PROCRIT , compared with patients treated, Aranesp , that that there is no need accrual.2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.. Flu-like symptoms strain of Chlamydia Used lower MSM in U.S., Increase HIV hazard.
An ‘abnormally virulent’strain of Chlamydia seem spread in the U.S., especially in men which have sex with men, concerns from among officials via an increased risk of of HIV gears research researchers said on Wednesday, that Los Angeles Times reports will shorten. – ‘Image courtesy of They can total Kaiser Daily Health Policy Reports view, Yearch the archives or sign up for email infeed to Emperor Daily Health policy coverage from strongly committed emperors network.